These results confirm that RHEBL1 and RNPC3 may be potential targets for Polyphyllin VI and Protodioscin in the treatment of non-small cell lung cancer and may also be candidate diagnostic genes for determining the prognosis associated with non-small cell lung cancer. Here, RHEBL1 is linked to non-small cell lung carcinoma.